From Liston Street Pulse:
British drug maker AstraZeneca (AZN) announced on Tuesday that its Medlmmune unit has agreed to buy a privately held biotech company, Spirogen in deal valued up to $440 million. The acquisition is expected to boost AstraZeneca's R&D plans in Oncology. Spirogen specializes in antibody drug conjugate technology, which has a […]
The post AstraZeneca Acquires Biotech Company Spirogen appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015